Back
Delegates Premium Access

Risk stratification strategies in patients receiving tyrosine kinase inhibitors: case presentation

Session: Guidelines in Practice: who is at risk of cardiovascular toxicity?
Topic: Cardiovascular Toxicity Stratification
Speaker: Doctor M. Mirabel (Paris, FR)
Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Mariana Mirabel

Montsouris Mutualist Institute, Paris (France)
8 presentations
3 followers

3 more presentations in this session

Risk stratification strategies in non-Hodgkin lymphoma: case presentation

Speaker: Professor J. Alexandre (Caen, FR)

Access
Slides
Video
Like
Thumbnail

What do the ESC Guidelines on Cardio-Oncology say and how should they be implemented?

Speaker: Professor J. Liu (New York, US)

Access
Slides
Video
Like
Thumbnail

Who is at risk of cardiovascular toxicity? - discussion

Access
Like
Thumbnail

Access the full session

Guidelines in Practice: who is at risk of cardiovascular toxicity?

Speakers: Doctor M. Mirabel, Professor J. Alexandre, Professor J. Liu
Access
Like
Thumbnail

About the event

Image

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources